ArticleRegenerative therapy2025

Amelioration of female menopausal syndrome by intravenous administration of autologous menstrual blood-derived stem cells.

Hiromi Izawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.